![Matthew Gline](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Gline
Algemeen Directeur bij
ROIVANT SCIENCES LTD.
Vermogen: 502 M $ op 31-05-2026
Profiel
Momenteel bekleedt Matthew Gline de functie van Chief Executive Officer & Director bij Roivant Sciences Ltd. en de functie van Chief Executive Officer voor Roivant Sciences GmbH en Chief Executive Officer voor Roivant Sciences, Inc. (beide zijn dochterondernemingen van Roivant Sciences Ltd.). Hij zit ook in de raad van bestuur van Sumitovant Biopharma, Inc. In zijn vorige loopbaan was de heer Gline Chief Executive Officer & Director bij Montes Archimedes Acquisition Corp. Matthew Gline behaalde een bachelordiploma aan Harvard College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 16-04-2026 | 16.736.116 ( 2,33% ) | 502 M $ | 31-05-2026 |
Actieve functies van Matthew Gline
| Bedrijven | Functie | Begin |
|---|---|---|
| ROIVANT SCIENCES LTD. | Algemeen Directeur | 01-01-2021 |
| ARBUTUS BIOPHARMA CORPORATION | Directeur/Bestuurslid | 24-02-2025 |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceutical products | Algemeen Directeur | 01-01-2021 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Algemeen Directeur | 01-01-2021 |
Roivant Social Ventures, Inc.
 Roivant Social Ventures, Inc. Roivant Social Ventures, Inc. is a not-for-profit social impact organization dedicated to advancing health equity by applying private sector strategies to biopharma innovation and healthcare delivery. The private company is based in New York, NY. The company focuses on ensuring equitable access to medicines and medical care regardless of geography, wealth, or insurance status by investing in early-stage companies developing therapies for underserved patient populations, incubating healthcare-focused social entrepreneurs, and embedding drug development education in academic institutions through fellowships and internships to promote diversity in the biopharma industry and clinical trials. Roivant Social Ventures also partners with companies, institutes, and organizations to create systemic improvements in healthcare access and delivery, with key focus areas including gene therapy access, increasing diversity in clinical trials, and fostering diversity, equity, and inclusion opportunities for future biopharma leaders. Lindsay Androski has been the CEO of the company since 2016. | Directeur/Bestuurslid | 01-03-2016 |
Datavant, Inc.
 Datavant, Inc. Packaged SoftwareTechnology Services Operates as a health care software data platform company | Directeur/Bestuurslid | - |
Eerdere bekende functies van Matthew Gline
| Bedrijven | Functie | Einde |
|---|---|---|
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01-01-2016 |
Fourthrev Ltd.
 Fourthrev Ltd. Packaged SoftwareTechnology Services Operates as an educational technology company that provides online learning program services | Oprichter | 01-03-2014 |
| BARCLAYS PLC | Corporate Officer/Principal | 01-01-2012 |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
Opleiding van Matthew Gline
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
73
Eerstegraads connecties
13
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 13 |
|---|---|
Arbutus Biopharma Corp.
 Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Roivant Sciences Ltd.
 Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
Barclays PLC
 Barclays PLC Investment Banks/BrokersFinance Operates as a bank holding company whose subsidiaries engages in retail banking, credit cards, corporate and investment banking and wealth management services | Finance |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceutical products | Health Technology |
Datavant, Inc.
Datavant, Inc. Packaged SoftwareTechnology Services Operates as a health care software data platform company | Technology Services |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Urovant Sciences Ltd.
 Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for urologic conditions | Health Technology |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets drugs | Health Technology |
Montes Archimedes Acquisition Corp.
 Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Fourthrev Ltd.
Fourthrev Ltd. Packaged SoftwareTechnology Services Operates as an educational technology company that provides online learning program services | Technology Services |
Roivant Social Ventures, Inc.
Roivant Social Ventures, Inc. Roivant Social Ventures, Inc. is a not-for-profit social impact organization dedicated to advancing health equity by applying private sector strategies to biopharma innovation and healthcare delivery. The private company is based in New York, NY. The company focuses on ensuring equitable access to medicines and medical care regardless of geography, wealth, or insurance status by investing in early-stage companies developing therapies for underserved patient populations, incubating healthcare-focused social entrepreneurs, and embedding drug development education in academic institutions through fellowships and internships to promote diversity in the biopharma industry and clinical trials. Roivant Social Ventures also partners with companies, institutes, and organizations to create systemic improvements in healthcare access and delivery, with key focus areas including gene therapy access, increasing diversity in clinical trials, and fostering diversity, equity, and inclusion opportunities for future biopharma leaders. Lindsay Androski has been the CEO of the company since 2016. |
